Through its modulation of the NNMT-SAM-NAD+ axis, it enhances energy expenditure and supports more efficient utilization of fat stores for energy, making it a strong candidate in studies exploring metabolic optimization and obesity control
5-Amino-1MQ inhibits the NNMT enzyme to theoretically raise NAD+ levels and improve insulin sensitivity, but evidence is limited to preclinical animal studies only
When NNMT is overactive in adipocytes, SAM is depleted reducing the cells capacity for methylation reactions that regulate gene expression, including the epigenetic programs that control energy expenditure
Since peptides like 5-Amino-1MQ naturally occur in the body in various forms, this therapy is designed to align closely with the bodys biological systems, making it a well-tolerated and promising option for those seeking enhanced metabolic health, longevity, and improved physical resilience
AOD-9604 isolates lipolysis as a variable, making it cleaner for adipocyte-specific experiments where you don't want confounding effects on glucose metabolism or growth pathways